Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK.
Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK. JCI Insight. 2019 10 17; 4(20).
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal, Humanized
Antibody-Dependent Cell Cytotoxicity
B7-H1 Antigen
Cell Line, Tumor
Female
Gene Knockdown Techniques
Humans
Immunotherapy
Killer Cells, Natural
Meningeal Neoplasms
Meningioma
Mice
Treatment Outcome
Xenograft Model Antitumor Assays
authors with profiles
Deric Park